Literature DB >> 23158101

Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

Tommy E White1, Alberto Brandariz-Nuñez, Jose Carlos Valle-Casuso, Sarah Amie, Laura Nguyen, Baek Kim, Jurgen Brojatsch, Felipe Diaz-Griffero.   

Abstract

The human SAMHD1 protein is a novel retroviral restriction factor expressed in myeloid cells. Previous work has correlated the deoxynucleotide triphosphohydrolase activity of SAMHD1 with its ability to block HIV-1 and SIV(mac) infection. SAMHD1 is comprised of the sterile alpha motif (SAM) and histidine-aspartic (HD) domains; however the contribution of these domains to retroviral restriction is not understood. Mutagenesis and deletion studies revealed that expression of the sole HD domain of SAMHD1 is sufficient to achieve potent restriction of HIV-1 and SIV(mac). We demonstrated that the HD domain of SAMHD1 is essential for the ability of SAMHD1 to oligomerize by using a biochemical assay. In agreement with previous observations, we mapped the RNA-binding ability of SAMHD1 to the HD domain. We also demonstrated a direct interaction of SAMHD1 with RNA by using enzymatically-active purified SAMHD1 protein from insect cells. Interestingly, we showed that double-stranded RNA inhibits the enzymatic activity of SAMHD1 in vitro suggesting the possibility that RNA from a pathogen might modulate the enzymatic activity of SAMHD1 in cells. By contrast, we found that the SAM domain is dispensable for retroviral restriction, oligomerization and RNA binding. Finally we tested the ability of SAMHD1 to block the infection of retroviruses other than HIV-1 and SIV(mac). These results showed that SAMHD1 blocks infection of HIV-2, feline immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV), Equine infectious anemia virus (EIAV), N-tropic murine leukemia virus (N-MLV), and B-tropic murine leukemia virus (B-MLV).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158101      PMCID: PMC3767443          DOI: 10.1016/j.virol.2012.10.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  38 in total

Review 1.  The many faces of SAM.

Authors:  Feng Qiao; James U Bowie
Journal:  Sci STKE       Date:  2005-05-31

Review 2.  Generation of high-titer pseudotyped retroviral vectors with very broad host range.

Authors:  J K Yee; T Friedmann; J C Burns
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

3.  HIV type 2 Vpx interaction with Gag and incorporation into virus-like particles.

Authors:  L Jin; Y Zhou; L Ratner
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

4.  Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).

Authors:  T M Fletcher; B Brichacek; N Sharova; M A Newman; G Stivahtis; P M Sharp; M Emerman; B H Hahn; M Stevenson
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

5.  Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.

Authors:  L Selig; J C Pages; V Tanchou; S Prévéral; C Berlioz-Torrent; L X Liu; L Erdtmann; J Darlix; R Benarous; S Benichou
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.

Authors:  J C Kappes; J S Parkin; J A Conway; J Kim; C G Brouillette; G M Shaw; B H Hahn
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

7.  Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles.

Authors:  I W Park; J Sodroski
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-12-15

8.  Progression to AIDS in the absence of a gene for vpr or vpx.

Authors:  J S Gibbs; A A Lackner; S M Lang; M A Simon; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3.

Authors:  H Schwende; E Fitzke; P Ambs; P Dieter
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

10.  Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification.

Authors:  V M Hirsch; M E Sharkey; C R Brown; B Brichacek; S Goldstein; J Wakefield; R Byrum; W R Elkins; B H Hahn; J D Lifson; M Stevenson
Journal:  Nat Med       Date:  1998-12       Impact factor: 87.241

View more
  78 in total

1.  Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cells.

Authors:  Joseph A Hollenbaugh; Susan M Schader; Raymond F Schinazi; Baek Kim
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

Review 2.  HIV suppression by host restriction factors and viral immune evasion.

Authors:  Xiaofei Jia; Qi Zhao; Yong Xiong
Journal:  Curr Opin Struct Biol       Date:  2015-05-16       Impact factor: 6.809

3.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

4.  Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins.

Authors:  Wei Wei; Haoran Guo; Qimeng Gao; Richard Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Structural basis of cellular dNTP regulation by SAMHD1.

Authors:  Xiaoyun Ji; Chenxiang Tang; Qi Zhao; Wei Wang; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

6.  The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch.

Authors:  Christopher H Mauney; LeAnn C Rogers; Reuben S Harris; Larry W Daniel; Nelmi O Devarie-Baez; Hanzhi Wu; Cristina M Furdui; Leslie B Poole; Fred W Perrino; Thomas Hollis
Journal:  Antioxid Redox Signal       Date:  2017-04-18       Impact factor: 8.401

7.  Impaired dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592.

Authors:  Chenxiang Tang; Xiaoyun Ji; Li Wu; Yong Xiong
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

8.  SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.

Authors:  Eui Tae Kim; Kathryn L Roche; Katarzyna Kulej; Lynn A Spruce; Steven H Seeholzer; Donald M Coen; Felipe Diaz-Griffero; Eain A Murphy; Matthew D Weitzman
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

9.  Promoter methylation regulates SAMHD1 gene expression in human CD4+ T cells.

Authors:  Suresh de Silva; Heather Hoy; Timothy S Hake; Henry K Wong; Pierluigi Porcu; Li Wu
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

10.  Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1.

Authors:  Sarah Welbourn; Klaus Strebel
Journal:  Virology       Date:  2015-12-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.